Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.
Andersson E, Shao W, Bontell I, Cham F, Cuong do D, Wondwossen A, Morris L, Hunt G, Sönnerborg A, Bertagnolio S, Maldarelli F, Jordan MR. Andersson E, et al. Among authors: cham f. Infect Genet Evol. 2013 Aug;18:125-31. doi: 10.1016/j.meegid.2013.03.050. Epub 2013 Apr 11. Infect Genet Evol. 2013. PMID: 23583545 Free PMC article.
Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low-income and middle-income countries.
Inzaule SC, Jordan MR, Cournil A, Girón-Callejas A, Avila-Rios S, Mulenga L, Ssemwanga D, Asio J, Diop-Ndiaye H, Niasse-Traore F, Nhan DT, Dat VQ, Aghokeng AF, Billong S, Cham F, Doherty M, Bertagnolio S; Acquired HIV Drug Resistance Survey Team. Inzaule SC, et al. Among authors: cham f. AIDS. 2020 Nov 1;34(13):1965-1969. doi: 10.1097/QAD.0000000000002623. AIDS. 2020. PMID: 32694410
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J, Takou D, Njume D, Pabo W, Santoro MM, Njom Nlend AE, Beloumou G, Sosso S, Moudourou S, Teto G, Dambaya B, Djupsa S, Tetang Ndiang S, Ateba FN, Billong SC, Kamta C, Bala L, Lambo V, Tala V, Chenwi Ambe C, Mpouel ML, Cappelli G, Cham F, Ndip R, Mbuagbaw L, Koki Ndombo P, Ceccherini-Silberstein F, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Among authors: cham f. HIV Med. 2021 Aug;22(7):567-580. doi: 10.1111/hiv.13095. Epub 2021 Mar 31. HIV Med. 2021. PMID: 33792134 Free article.
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens.
Fokam J, Takou D, Semengue ENJ, Teto G, Beloumou G, Dambaya B, Santoro MM, Mossiang L, Billong SC, Cham F, Sosso SM, Temgoua ES, Nanfack AJ, Moudourou S, Kamgaing N, Kamgaing R, Ngako Pamen JN, Etame MMN, Bissek AZ, Elat JN, Moussi EE, Colizzi V, Perno CF, Ndjolo A; VIROFORUM. Fokam J, et al. Among authors: cham f. Antimicrob Resist Infect Control. 2020 Aug 26;9(1):143. doi: 10.1186/s13756-020-00799-2. Antimicrob Resist Infect Control. 2020. PMID: 32843050 Free PMC article.
33 results